HealthCare Middle East & Africa Magazine News- WEEK -28

AFRICAN ?NEWS HEADLINES ?

Kenya’s Ministry of Health mandates NHIF to settle US$216.9M debts before October ?

KENYA –The Ministry of Health has mandated the National Health Insurance Fund (NHIF) to clear all its outstanding debts to service providers before its scheduled closure in October?. . .?More

Redhill Cancer Hospital, Siemens Healthineers partner to build Africa’s most advanced cancer center in Nairobi

KENYA – Redhill Cancer Hospital, under the umbrella of RVL Healthcare Ltd and Siemens Healthineers, have joined forces to create a revolutionary integrated cancer center and research park in Nairobi, Kenya?. . .?More

South Africa Netcare Hospital Wins International Digital Innovation Award

SOUTH AFRICA – Netcare, a leading private healthcare provider in South Africa, won the prestigious Digital Innovation Award at the seventh annual International Quality Awards in London?. . .?More

Africa CDC pushes for affordable scientific publication charges to boost African research output

GHANA – The Africa CDC?has advocated for reduced article processing charges to facilitate the publication of scientific findings by more African countries and researchers?. . .?More

MIDDLE EAST NEWS HEADLINES ?

Abu Dhabi University , Burjeel Holdings join forces to advance healthcare research in the UAE

UAE — Abu Dhabi University (ADU) and Burjeel Holdings have formed a strategic partnership?to develop research and improve academic experiences in the UAE. . .?More

PureHealth strengthens regional leadership with strategic sale and SSMC focus

UAE— PureHealth, the Middle East’s largest healthcare platform, has announced the sale of its entire stake in Abu Dhabi Stem Cells Centre (ADSCC) and Yas Clinic Group (Yas Clinic)?. . .?More

American Hospital Dubai expands excellence in scoliosis treatment

UAE—The American Hospital Dubai’s Scoliosis Centre has expanded its footprint of excellence in complex disease management in the UAE?. .?.?More

WORLD NEWS HEADLINES

Eisai, Bristol Myers Squibb terminates collaboration on cancer drug

JAPAN— Eisai has cancelled its collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin (FZEC), a dual-acting drug designed to treat lung and ovarian cancer?. . .?More

GSK, CureVac restructures collaboration into new licensing agreement

UK — GSK plc and CureVac N.V. have restructured their existing collaboration into a new licensing agreement, allowing each company to prioritize investment and focus on their respective mRNA development activities. . .?More

Beacon Therapeutics secures US$170M in Series B Funding?

UK—Beacon Therapeutics Holdings Limited, a leading ophthalmic gene therapy company dedicated to saving and restoring patients’ vision with blinding retinal diseases, has raised US $170 million in Series B funding?. . .?More